- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA ruled Takeda’s ASH highlights webinar was not genuine scientific exchange and promoted ixazomib for an unlicensed frontline myeloma indication. Breaches of…
Ever Pharma’s Dacepton leavepieces breached the ABPI Code for misleading stability and cost-saving claims that omitted microbiological contamination caveats from the SPC.…
Sanofi emails to GP customers and an NHS manager suggested QIVe orders were “fully reimbursable” and criticised local NHS interpretation. PMCPA found…
Anonymous health professional alleged Sanofi promoted Suliqua for use alongside basal insulin, risking overdose. Panel found insufficient evidence and ruled no breach…
A sponsored symposium recording about Lixiana was uploaded to Vimeo with incorrect privacy settings, making it viewable by the public. Breach found…
A health professional complained about a Chiesi asthma webinar. The Panel found breaches for unreadable/too-brief prescribing information and describing Trimbow as “safe”.…
A creative agency posted Itulazax (POM) campaign frames on Instagram after the contract ended. Panel found a Clause 3.2 breach, but the…
Ex-employee alleged a post-ASH ‘scientific exchange’ was disguised promotion. Panel found meeting non-promotional but ruled breaches for high standards (misleading terminology) and…
A third-party web contractor inadvertently removed APO-go prescribing information during remediation work, leaving PI inaccessible for over 24 hours. PMCPA ruled a…
Novo Nordisk admitted certification failures for a password-protected obesity/weight management hub hosted on an association website. Panel found poor oversight and ruled…
Four Novartis-funded Leqvio (inclisiran) supplement articles were accessible without the landing page and omitted the black triangle; printed versions appeared to lack…
HSJ “sponsored” article on AF/stroke was not clear at the outset that it was written by a senior Daiichi Sankyo employee. Breach…
AstraZeneca was ruled in breach of Clause 8.1 after the Forxiga diabetes webpage differed between desktop and mobile (audience banner shown on…
A Ferinject promotional article in the British Journal of Cardiology used “safe” in key messages without adequate qualification. Breach of Clause 7.9…
Amgen-sponsored webinar invite and downloadable infographic looked like they were from an independent organisation. Sponsorship disclosure appeared too late and wording was…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.